Establish clear objectives and appropriate leading and lagging performance measures for diagnostics and patient-finding programs, including testing adoption, workflow implementation, diagnostic completion, referral pathway effectiveness, time to diagnosis/referral, program reach, sustainability, scalability, and other appropriate measures, in partnership with Analytics and relevant governance functions. The Associate Director, Marketing will serve as the commercial lead for Hepatitis Delta (HDV) diagnostics and patient finding, with responsibility for building scalable capabilities that increase testing, identify undiagnosed patients, understand 'diagnostic leakage' and improve the pathway from diagnosis through referral to appropriate care.